Clinical trial
Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 Days) With Suspected or Complicated Intra-abdominal Infections
NCT00621192 is registered in ClinicalTrials.gov with The Emmes Company, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 Days) With Suspected or Complicated Intra-abdominal Infections
- Lead sponsor
- The Emmes Company, LLC
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- October 31, 2009
- Enrollment
- 200 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
intra-abdominal infection, necrotizing enterocolitis